Summer 2026
Special: Drug Delivery Services
For years, drug delivery sat downstream of discovery but that hierarchy is changing. In a market shaped by biologics, chronic disease, payer pressure and overloaded health systems, how a medicine reaches the patient can be as important as what it targets.
Drug discovery is nolonger only a race to find the right molecule. As biologics, GLP-1s, biosimilars and high-dose therapies reshape pipelines, the route of administration is becoming a strategic battleground. Devices, formulations and delivery platforms now influence differentiation, adherence, market access and even the commercial fate of new medicines.
- Drug delivery: The route becomes the product
- The connective matrix: ELRIG’s role in the drug discovery ecosystem
- Inside Exosomes: Nature’s drug carriers
- Cell therapies: breaking barriers in solid tumours
- Drug delivery nanogel to transform medical devices
- AI: Breaking barriers in CNS research
This Special is part of European Biotechnology Magazine Summer 2026.
